Sign In
Buy INRLF
$2.74
+0.160 (+6.20%)
At Close: Jun 03, 2026
Valneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race
04:17am, Tuesday, 18'th Jul 2023
Positive Phase 3 data from Bavarian Nordic's chikungunya virus (CHIKV) vaccine candidate, PXVX0317, reinforces bullish view on Valneva's VLA1553 due to its superior clinical profile. Valneva's VLA1553
Valneva SE (VALN) Q1 2023 Earnings Call Transcript
10:10pm, Saturday, 06'th May 2023
Valneva SE (NASDAQ:VALN ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - Chairman, President & CEO Peter Buhler - CFO Conference
Valneva SE (VALN) Q4 2022 Earnings Call Transcript
01:25pm, Thursday, 23'rd Mar 2023
Valneva SE (NASDAQ:VALN ) Q4 2022 Earnings Conference Call March 23, 2023 10:00 AM ET Company Participants Joshua Drumm - Vice President of Investor Relations Thomas Lingelbach - Chief Executive Offic
Will A Pfizer-Partnered Vaccine Help Valneva Stock Buck Its Recent Downtrend?
10:42am, Thursday, 01'st Dec 2022
Valneva stock rose Thursday after it said volunteers who received its Pfizer-partnered Lyme disease shot still had antibodies after six months. The post Will A Pfizer-Partnered Vaccine Help Valneva St
Valneva SE (VALN) Q3 2022 Earnings Call Transcript
03:52pm, Thursday, 10'th Nov 2022
Valneva SE (NASDAQ:VALN ) Q3 2022 Earnings Conference Call November 10, 2022 9:00 AM ET Company Participants Thomas Lingelbach – President and Chief Executive Officer Peter Buhler – Chief Financia
Valneva cuts full-year outlook on lower COVID-19 vaccine sales
01:31am, Thursday, 11'th Aug 2022
Vaccine developer Valneva on Thursday cut its full-year revenue outlook to account for lower orders of its COVID-19 vaccine after both the European Union and the UK walked away from supply contracts w
Pfizer, Valneva begin major test of first possible Lyme vaccine in 20 years
05:19pm, Monday, 08'th Aug 2022
DUNCANSVILLE, Pa. — Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years — in hopes of better fighting the
Valneva (VALN) Stock: Why It Skyrocketed 93.14% Today
05:46pm, Tuesday, 21'st Jun 2022
The stock price of Valneva SE (NASDAQ: VALN) surged by 93.14% today. This is why.
Why Shares Of Valneva SE Are Soaring Today
12:33pm, Tuesday, 21'st Jun 2022
Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and
This biotech stock is up 100% on Tuesday: here's the catalyst
12:08pm, Tuesday, 21'st Jun 2022
Pfizer Inc (NYSE: PFE), on Tuesday, doubled down on its partnership with Valneva SE (NASDAQ: VALN) to develop a vaccine for Lyme disease. Shares of the French biotech firm are up nearly 100% this morn
Why Is Valneva (VALN) Stock Up 85% Today?
09:45am, Tuesday, 21'st Jun 2022
Valneva (VALN) stock is rocketing higher on Tuesday following news that Pfizer (PFE) is taking a stake in the vaccine company. The post Why Is Valneva (VALN) Stock Up 85% Today?
The Shopify Split Is Just Days Away, but This Tiny Nasdaq Stock Is Soaring Right Now
08:10am, Tuesday, 21'st Jun 2022
Markets looked poised for a rebound on Tuesday.
Pfizer makes equity investment in Valneva as they prepare for Phase 3 trial of Lyme disease vaccine candidate
07:42am, Tuesday, 21'st Jun 2022
U.S.-listed shares of Valneva VALN, -13.47% soared 81.9% in premarket trading on Tuesday, the day after Pfizer Inc. PFE, -2.00% announced a $95 million equity investment in Valneva as part of a previo
Pfizer to buy 8.1% of capital of vaccines company Valneva
01:21am, Monday, 20'th Jun 2022
French specialty vaccine company Valneva and U.S. healthcare giant Pfizer said they had entered an equity subscription agreement under which Pfizer will invest 90.5 million euros ($95.24 million) in V
Valneva's stock slides after saying Europe may not order the company's COVID-19 vaccine candidate
08:31am, Monday, 13'th Jun 2022
Shares of Valneva SE VALN, -14.89% fell 13.3% in premarket trading on Monday after the company said it proposed a remediation plan to the European Commission after learning of plans to terminate the p
